- Joined
- Dec 17, 2007
- Messages
- 3,413
- Reaction score
- 4,444
Ok I have a question:
What is the general management in your clinic for chloroma / myeloid sarcoma and CNS involvement?
Case 1:
Patient is diagnosed with AML. MRI scans reveal epidural involvement Th5-Th9. Patient shows no neurologic symptoms, CSF is negative. He receives high dose induction chemotherapy for 2 cycles with intrathecal chemotherapy prophylaxis. Follow up MRIs show epidural CR and bone marrow shows CR.
Patient is scheduled thus for allogeneic stem cell transplantation, conditioning is scheduled to include TBI 12 Gy (6x2Gy).
Would you treat this patient more aggressively (for example TBI 6x2 Gy + upfront TH5-9)? To what doses?
Case 2:
Patient diagnosed with ALL. CSF is positive, cranial MRI reveals dural enhancement, without any larger lesions. Patient shows no neurologic symptoms. He receives induction chemotherapy, including intrathecal chemotherapy. Follow up MRIs show epidural CR, CSF and bone marrow shows CR.
Patient is scheduled thus for allogeneic stem cell transplantation, conditioning is scheduled to include TBI 12 Gy (6x2Gy).
Would you treat this patient more aggressively (for example TBI 6x2 Gy + upfront CSI or only WBRT)? To what doses?
There is some evidence out there for more aggressive CNS treatment i high risk patients, but most of the studies conducted are on children.
A very interesting German study showed that treating mediastinal bulk lesions in children with ALL did not improve prognosis. This has led many physicians to abandoning local radiation therapy for childdren with chloromas from ALL. However I am not sure if the same results can be extrapolated to older patients.
Children have excellent prognosis with ALL. 90%+ survive ALL, so the potential benefits of thoracic irradiation would have to be quite high in order to show a true benefit, because the margin for bettering the outcome are quite small.
On the other hand patients elder than 18-20, show a worse prognosis when diagnosed with ALL. Perhaps in these patients, local chloroma radiation treatment may enhance prognosis.
What is the general management in your clinic for chloroma / myeloid sarcoma and CNS involvement?
Case 1:
Patient is diagnosed with AML. MRI scans reveal epidural involvement Th5-Th9. Patient shows no neurologic symptoms, CSF is negative. He receives high dose induction chemotherapy for 2 cycles with intrathecal chemotherapy prophylaxis. Follow up MRIs show epidural CR and bone marrow shows CR.
Patient is scheduled thus for allogeneic stem cell transplantation, conditioning is scheduled to include TBI 12 Gy (6x2Gy).
Would you treat this patient more aggressively (for example TBI 6x2 Gy + upfront TH5-9)? To what doses?
Case 2:
Patient diagnosed with ALL. CSF is positive, cranial MRI reveals dural enhancement, without any larger lesions. Patient shows no neurologic symptoms. He receives induction chemotherapy, including intrathecal chemotherapy. Follow up MRIs show epidural CR, CSF and bone marrow shows CR.
Patient is scheduled thus for allogeneic stem cell transplantation, conditioning is scheduled to include TBI 12 Gy (6x2Gy).
Would you treat this patient more aggressively (for example TBI 6x2 Gy + upfront CSI or only WBRT)? To what doses?
There is some evidence out there for more aggressive CNS treatment i high risk patients, but most of the studies conducted are on children.
A very interesting German study showed that treating mediastinal bulk lesions in children with ALL did not improve prognosis. This has led many physicians to abandoning local radiation therapy for childdren with chloromas from ALL. However I am not sure if the same results can be extrapolated to older patients.
Children have excellent prognosis with ALL. 90%+ survive ALL, so the potential benefits of thoracic irradiation would have to be quite high in order to show a true benefit, because the margin for bettering the outcome are quite small.
On the other hand patients elder than 18-20, show a worse prognosis when diagnosed with ALL. Perhaps in these patients, local chloroma radiation treatment may enhance prognosis.
Last edited: